Login / Signup

Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.

Ronald F Van VollenhovenKenneth C KalunianThomas DörnerBevra H HahnYoshiya TanakaRobert M GordonCathye ShuKaiyin FeiSheng GaoLoqmane SeridiPatrick GallagherKim Hung LoPamela BerryQing C Zuraw
Published in: Annals of the rheumatic diseases (2022)
NCT03517722.
Keyphrases
  • double blind
  • clinical trial
  • placebo controlled
  • study protocol
  • open label
  • randomized controlled trial
  • cross sectional